Global temporal trends and projections of hepatitis B-related cirrhosis among adolescents and young adults from 1990 to 2035: an analysis based on the global burden of disease study 2021
Open Access
- 8 January 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1494388
Abstract
Background: Chronic hepatitis B and cirrhosis pose significant global health threats. Few studies have explored the disease burden and mortality trend of cirrhosis caused by hepatitis B virus infection among adolescents and young adults (AYAs, aged 15–39 years). This study aimed to assess the disease burden and trends.Methods: Publicly available data were obtained from the 2021 GBD database. The rates of incidence, mortality, and disability-adjusted life years were calculated at the global, regional, and national levels. Temporal trends were assessed using joinpoint regression analysis, while the Bayesian age-period-cohort model was used to predict future trends.Results: From 1990 to 2021, the global incidence rate of hepatitis B-related cirrhosis decreased from 111.33 (95% uncertainty interval: 89.18 to 134.98) to 67.75 (54.06 to 82.71) per 100,000 with an average annual percentage change of −1.58 (95% confidence interval: −1.66 to −1.51, p < 0.001). However, between 1990 and 2021, the incidence numbers in the 30–34 and 35–39 age groups increased by 23.75 and 21.24%, respectively. The number of deaths in low and low-middle Socio-demographic Index (SDI) areas increased by 79.51 and 20.62%, respectively. Moreover, it is predicted that the numbers of incidences and deaths will continue to rise in areas with low SDI. At the regional level, Central Sub-Saharan Africa had the highest incidence and mortality rates. In 2021, Somalia and the Democratic Republic of Congo had the highest incidence rates, whereas Kiribati and Cambodia had the highest mortality rates.Conclusion: The overall burden of hepatitis B-related cirrhosis among AYAs has decreased over the past three decades. Nevertheless, there was a slight increase in the incidence number among individuals aged 30–39 years. The substantial burden and predicted rise in the numbers of incidences and deaths in low SDI areas underscore the need for sustained and targeted public health interventions.Keywords
This publication has 36 references indexed in Scilit:
- Trends in the incidence of cirrhosis in global from 1990 to 2019: A joinpoint and age‐period‐cohort analysisJournal of Medical Virology, 2023
- Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impactStatistics in Medicine, 2022
- Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019Cancer Medicine, 2022
- Global burden of NAFLD and chronic liver disease among adolescents and young adultsHepatology, 2021
- Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020Cancer Communications, 2021
- Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemicHepatology, 2017
- Projecting the future burden of cancer: Bayesian age–period–cohort analysis with integrated nested Laplace approximationsBiometrical Journal, 2017
- Hepatitis B virus genotypes: epidemiological and clinical relevance in AsiaHepatology International, 2016
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International, 2015
- Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization programHepatology, 2011